Shield Therapeutics PLC Sustainability Reports
Shield Therapeutics PLC is a commercial-stage pharmaceutical company focused on the development and commercialization of late-stage hospital-focused pharmaceuticals. Its flagship product is ACCRUFER/Feraccru, an oral iron therapy treatment for iron deficiency.
Sector: Manufacturing
Country: United Kingdom
Exchange: London Stock Exchange (AIM)
LEI: 213800G74QWY15FC3W71
FIGI: BBG001V1HSH2
9 reports from 2015 to 2025